RxDoctor Payments Data
★ My doctorsLook up a doctor →

Debabrata Ghosh, MD

Neurology with Special Qualifications in Child Neurology · Elyria, OHNPI 1356446595

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 193 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 23.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $818, more than ten times the $60 reported in 2019.

$3,947in general payments, 2019–2025

Across 193 payments — averaging $20.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • UCB, Inc.$909
  • Neurelis, Inc.$708
  • Supernus Pharmaceuticals, Inc.$263
  • Collegium Pharmaceutical, Inc.$253
  • Jazz Pharmaceuticals Inc.$233
  • Genentech USA, Inc.$162
  • plus $1K from 30 others

What the payments were for

  • Food & beverage$3,947100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
UCB, Inc.39$909
Neurelis, Inc.35$708
Supernus Pharmaceuticals, Inc.14$263
Collegium Pharmaceutical, Inc.15$253
Jazz Pharmaceuticals Inc.8$233
Genentech USA, Inc.8$162
Greenwich Biosciences, Inc.5$137
AbbVie(2 entities)7$123
Acadia Pharmaceuticals Inc5$109
Eisai Inc.5$94
SK Life Science, Inc.5$87
Biogen4$80
Catalyst Pharmaceuticals, Inc.4$77
Tris Pharma Inc4$67
Livanova USA, Inc.3$50
EMD Serono, Inc.2$49
Teva Pharmaceuticals USA, Inc.3$48
Novartis3$47
Harmony Biosciences LLC2$47
Adamas Pharmaceuticals, Inc.2$39
Banner Life Sciences, LLC2$37
Ironshore Pharmaceuticals Inc.2$35
Mallinckrodt Hospital Products Inc.2$34
Springworks Therapeutics, Inc.1$33
Acorda Therapeutics, Inc2$23
TG Therapeutics, Inc.1$23
Abbott1$22
Zogenix Inc.1$21
Biomarin Pharmaceutical Inc.1$21
Grifols USA, LLC1$20
Corium, LLC1$19
Amgen1$18
Lundbeck LLC1$16
Arbor Pharmaceuticals, Inc.1$16
Sunovion Pharmaceuticals Inc.1$14
Neos Therapeutics, LP1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,947 in reported general payments places this provider in the 65th percentile of 113 neurology with special qualifications in child neurology providers in Ohio.

See all neurology with special qualifications in child neurology providers in Ohio →

Medicare billing

Part B allowed, 2024
$19,869
Medicare patients
53
Services billed
471

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology with special qualifications in child neurology in Elyria

See the full list for Ohio →

Where these figures come from

Is this you, or does something look wrong? →